tradingkey.logo
搜索
市场行情
自选
新闻
分析
交易工具
选股器
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
搜索

Lineage Cell Therapeutics Inc

LCTX
添加自选
1.010USD
-0.020-1.94%
收盘 09-21 16:00（美东）
256.70M总市值
亏损市盈率 TTM

Lineage Cell Therapeutics Inc

1.010
-0.020-1.94%
概览
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

概览

财务

股票评分

技术分析

预测

持股情况

股息

公司资料

财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

LCTX 财务数据

通过专为投资者打造的一站式数据看板，全面查看 Lineage Cell Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值
256.70M
股息TTM
0.00
市盈率 TTM
-3.66
每股收益TTM
-0.28
营业收入
14.56M
净利润
-18.61M
净资产收益率
-96.62%
总资产收益率
-57.86%

Lineage Cell Therapeutics Inc 财报日历

最新发布
8月 6, 2026
每股收益 / 预测值
0.01/-0.03
营业收入 / 预测值
1.07M/1.53M

财务报表摘要

单季报
单季报+年报
单季报
年报
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
104.45%0.01
-7.26%-0.02
126.34%0.00
-709.77%-0.13
-337.27%-0.13
48.81%-0.02
50.04%-0.01
60.48%-0.02
0.46%-0.03
-39.18%-0.04
27.02%-0.03
---0.04
---0.03
---0.03
---0.04
---0.12
----
----
----
----
营业收入
-61.34%1.07M
14.85%1.73M
130.40%6.61M
-2.59%3.68M
96.38%2.77M
4.02%1.50M
37.36%2.87M
203.29%3.78M
-56.34%1.41M
-39.48%1.44M
9.03%2.09M
-58.44%1.25M
-29.17%3.23M
-54.44%2.39M
63.96%1.92M
32.07%3.00M
789.26%4.55M
1239.39%5.24M
229.01%1.17M
297.55%2.27M
净利润
104.86%1.48M
-16.26%-4.81M
126.00%851.00K
-881.58%-29.78M
-428.89%-30.46M
36.73%-4.14M
31.46%-3.27M
57.33%-3.03M
-10.15%-5.76M
-49.63%-6.54M
24.85%-4.78M
-17.15%-7.11M
22.68%-5.23M
38.31%-4.37M
78.08%-6.35M
22.42%-6.07M
-41.25%-6.76M
-400.49%-7.09M
-1526.67%-28.99M
-0.81%-7.82M
利润率
113.15%144.43%
-0.65%-277.62%
111.91%13.50%
-917.80%-808.26%
-167.83%-1098.16%
39.26%-275.83%
49.81%-113.32%
86.18%-79.41%
-154.14%-410.01%
-146.05%-454.16%
32.04%-225.77%
---574.48%
---161.33%
---184.58%
---332.22%
---156.33%
----
----
----
----
毛利率
1.43%100.00%
2.46%100.00%
4.62%99.00%
0.88%99.86%
1.77%98.59%
4.71%97.60%
7.85%94.63%
14.53%98.99%
0.85%96.88%
-1.89%93.21%
-7.32%87.74%
--86.44%
--96.06%
--95.01%
--94.67%
--95.10%
----
----
----
----
资产负债率
-58.13%0.05%
-48.51%0.05%
-43.12%0.06%
-33.25%0.09%
-2.67%0.11%
-18.85%0.10%
-23.88%0.11%
-3.12%0.14%
-25.84%0.11%
-27.41%0.12%
45.88%0.14%
--0.14%
--0.15%
--0.16%
--0.10%
--0.03%
----
----
----
----
利润表
营业收入
-61.34%1.07M
14.85%1.73M
130.40%6.61M
-2.59%3.68M
96.38%2.77M
4.02%1.50M
37.36%2.87M
203.29%3.78M
-56.34%1.41M
-39.48%1.44M
9.03%2.09M
-58.44%1.25M
-29.17%3.23M
-54.44%2.39M
63.96%1.92M
32.07%3.00M
789.26%4.55M
1239.39%5.24M
229.01%1.17M
297.55%2.27M
营业利润
-80.63%-8.92M
-16.73%-7.59M
-28.14%-6.55M
1.41%-3.79M
15.80%-4.94M
2.34%-6.50M
19.68%-5.11M
42.73%-3.84M
-16.78%-5.87M
-0.29%-6.66M
4.17%-6.36M
-27.69%-6.71M
-18.66%-5.02M
-3.85%-6.64M
76.49%-6.64M
23.26%-5.25M
40.20%-4.23M
9.28%-6.40M
-380.07%-28.24M
-1.75%-6.84M
净利润
104.86%1.48M
-16.26%-4.81M
126.00%851.00K
-881.58%-29.78M
-428.89%-30.46M
36.73%-4.14M
31.46%-3.27M
57.33%-3.03M
-10.15%-5.76M
-49.63%-6.54M
24.85%-4.78M
-17.15%-7.11M
22.68%-5.23M
38.31%-4.37M
78.08%-6.35M
22.42%-6.07M
-41.25%-6.76M
-400.49%-7.09M
-1526.67%-28.99M
-0.81%-7.82M
资产负债表
流动资产
20.81%52.97M
12.36%56.16M
16.00%59.16M
22.85%42.26M
8.55%43.84M
9.34%49.98M
32.66%51.00M
-20.88%34.40M
-16.71%40.39M
-7.93%45.72M
-35.93%38.44M
-36.53%43.48M
-34.49%48.49M
-39.35%49.66M
-46.21%60.00M
0.24%68.51M
3.42%74.03M
26.69%81.87M
153.53%111.55M
72.00%68.34M
流动负债总额
-25.47%8.02M
-37.75%8.15M
-18.67%11.37M
-32.33%9.38M
-29.58%10.76M
-22.50%13.09M
-22.18%13.98M
-12.70%13.86M
-4.84%15.28M
-1.94%16.89M
-5.38%17.96M
-30.16%15.88M
-36.02%16.05M
-29.96%17.23M
-59.71%18.98M
158.66%22.74M
270.73%25.09M
271.44%24.59M
506.46%47.12M
13.42%8.79M
总资产
16.98%106.22M
-1.99%109.53M
-0.56%112.58M
-7.20%89.64M
-11.68%90.80M
3.01%111.75M
12.08%113.22M
-9.00%96.59M
-7.96%102.80M
-4.17%108.48M
-18.31%101.02M
-19.06%106.15M
-17.83%111.69M
-21.67%113.20M
-29.15%123.66M
-0.05%131.15M
0.87%135.92M
12.97%144.52M
61.69%174.54M
27.28%131.21M
总负债
6.26%46.42M
66.69%56.84M
91.23%69.24M
116.49%68.84M
21.60%43.69M
-9.06%34.10M
-7.15%36.21M
-19.48%31.80M
-11.14%35.93M
-15.16%37.49M
-24.61%39.00M
-26.31%39.49M
-25.71%40.43M
-25.48%44.19M
-38.16%51.73M
361.11%53.59M
387.97%54.42M
422.12%59.30M
552.37%83.65M
-9.94%11.62M
总权益
26.93%59.80M
-32.14%52.70M
-43.72%43.35M
-67.90%20.80M
-29.55%47.11M
9.39%77.66M
24.17%77.01M
-2.80%64.79M
-6.15%66.88M
2.86%70.99M
-13.78%62.02M
-14.05%66.66M
-12.57%71.26M
-19.01%69.02M
-20.86%71.94M
-35.15%77.55M
-34.06%81.50M
-26.90%85.22M
-4.45%90.90M
32.61%119.59M
现金流量表
经营净额
-30.78%-7.24M
-65.33%-8.08M
23.13%-4.88M
37.52%-3.62M
-7.01%-5.54M
15.51%-4.89M
-5.43%-6.35M
-14.89%-5.79M
17.42%-5.18M
48.56%-5.78M
27.51%-6.02M
8.08%-5.04M
11.24%-6.27M
-151.32%-11.24M
-41.38%-8.30M
-13.04%-5.48M
-30.39%-7.06M
395.04%21.90M
-4.11%-5.87M
-0.02%-4.85M
投资净额
28385.71%3.96M
-222.23%-2.33M
-681.94%-15.33M
-100.31%-12.00K
99.84%-14.00K
5107.89%1.90M
-72.95%2.63M
83.22%3.89M
-145.89%-8.79M
-100.25%-38.00K
290.94%9.74M
105.19%2.12M
19851.55%19.16M
33634.78%15.43M
-3394.52%-5.10M
-60067.65%-40.91M
15.65%-97.00K
-100.46%-46.00K
-116.19%-146.00K
-138.20%-68.00K
融资净额
1554.72%4.47M
10.25%5.56M
-6.23%20.38M
61233.33%1.83M
-392.38%-307.00K
-64.03%5.04M
167284.62%21.73M
-100.37%-3.00K
-98.13%105.00K
1402000.00%14.02M
-110.66%-13.00K
-16.29%807.00K
16954.55%5.63M
-99.81%1.00K
-87.21%122.00K
-74.08%964.00K
-99.71%33.00K
-97.55%513.00K
-80.18%954.00K
-84.86%3.72M

营业收入

业务

报告期:
暂无数据

地区

报告期:
暂无数据

常见问题

Lineage Cell Therapeutics Inc的总收入是多少？

根据Lineage Cell Therapeutics Inc的FY2025财报，总收入达到了14.56M（同比变化9.50M）。

Lineage Cell Therapeutics Inc的流动资产是多少？

根据Lineage Cell Therapeutics Inc的FY2025财报，流动资产为59.16M（同比变化16.00）。

Lineage Cell Therapeutics Inc的总资产是多少？

根据Lineage Cell Therapeutics Inc的FY2025财报，Lineage Cell Therapeutics Inc的总资产为112.58M（同比变化-0.56）。

Lineage Cell Therapeutics Inc的总负债是多少？

根据Lineage Cell Therapeutics Inc的FY2025财报，Lineage Cell Therapeutics Inc的总负债为69.24M（同比变化91.23）。

Lineage Cell Therapeutics Inc的总权益是多少？

根据Lineage Cell Therapeutics Inc的FY2025财报，Lineage Cell Therapeutics Inc的总权益为43.35M（同比变化-43.72）。

Lineage Cell Therapeutics Inc的净营业收入是多少？

根据Lineage Cell Therapeutics Inc的FY2025财报，Lineage Cell Therapeutics Inc的净营业收入为-21.78M（同比变化-1.40）。

Lineage Cell Therapeutics Inc的净投资是多少？

根据Lineage Cell Therapeutics Inc的FY2025财报，Lineage Cell Therapeutics Inc的净投资为-13.46M（同比变化-483.06）。

Lineage Cell Therapeutics Inc的净融资是多少？

根据Lineage Cell Therapeutics Inc的FY2025财报，Lineage Cell Therapeutics Inc的净融资为26.95M（同比变化-24.84）。

Lineage Cell Therapeutics Inc的每股收益（EPS）是多少？

根据Lineage Cell Therapeutics Inc的FY2025财报，每股收益（EPS）为-0.28（同比变化-197.00）。

Lineage Cell Therapeutics Inc的净利润是多少？

根据Lineage Cell Therapeutics Inc的FY2025财报，净利润为-63.53M（同比变化-241.41）。

Lineage Cell Therapeutics Inc的净利润率是多少？

根据Lineage Cell Therapeutics Inc的FY2025财报，净利润率为-435.33（同比变化-122.54）。

Lineage Cell Therapeutics Inc的毛利率是多少？

根据Lineage Cell Therapeutics Inc的FY2025财报，毛利率为99.00（同比变化2.60）。

Lineage Cell Therapeutics Inc的债务与资产比率是多少？

根据Lineage Cell Therapeutics Inc的FY2025财报，债务与资产比率为0.06（同比变化-43.12）。

Lineage Cell Therapeutics Inc的股东权益回报率（ROE）是多少？

根据Lineage Cell Therapeutics Inc的FY2025财报，股东权益回报率（ROE）为-103.36（同比变化-293.82）。

Lineage Cell Therapeutics Inc的资产回报率（ROA）是多少？

根据Lineage Cell Therapeutics Inc的FY2025财报，资产回报率（ROA）为-56.13（同比变化-223.55）。

Lineage Cell Therapeutics Inc的营业利润是多少？

根据Lineage Cell Therapeutics Inc的FY2025财报，营业利润为-21.78M（同比变化-1.40）。
tradingkey.logo
风险提示：我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐，且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险，包括可能损失投资的本金，且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告，并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
一般使用条款
隐私政策
Cookie政策